173 related articles for article (PubMed ID: 18508492)
1. Roles of CD4+CD25(high) FOXP3+ Tregs in lymphomas and tumors are complex.
Ke X; Wang J; Li L; Chen IH; Wang H; Yang XF
Front Biosci; 2008 May; 13():3986-4001. PubMed ID: 18508492
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of mouse CD4+CD25+Foxp3+ regulatory T cells in xenogeneic pig thymus-grafted nude mice suffering from autoimmune diseases.
Zhang B; Sun C; Qu Y; Zhang A; Liu J; Zhang L; Niu Z; Zhao Y
Cell Mol Immunol; 2008 Oct; 5(5):325-32. PubMed ID: 18954555
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression.
Ji J; Cloyd MW
Int Immunol; 2009 Mar; 21(3):283-94. PubMed ID: 19208751
[TBL] [Abstract][Full Text] [Related]
4. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer.
Loddenkemper C; Hoffmann C; Stanke J; Nagorsen D; Baron U; Olek S; Huehn J; Ritz JP; Stein H; Kaufmann AM; Schneider A; Cichon G
Cancer Sci; 2009 Jun; 100(6):1112-7. PubMed ID: 19514119
[TBL] [Abstract][Full Text] [Related]
5. CD4+CD25+ regulatory T cells in tumor immunity.
Chen X; Du Y; Lin X; Qian Y; Zhou T; Huang Z
Int Immunopharmacol; 2016 May; 34():244-249. PubMed ID: 26994448
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
7. Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency.
Arandi N; Mirshafiey A; Abolhassani H; Jeddi-Tehrani M; Edalat R; Sadeghi B; Shaghaghi M; Aghamohammadi A
Scand J Immunol; 2013 May; 77(5):405-12. PubMed ID: 23432692
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency of CD4+ CD25+ FOXP3+ cells correlates with the progression of 4-nitroquinoline1-oxide-induced rat tongue carcinogenesis.
Zhao J; Wang Z; Han J; Qiu X; Pan J; Chen J
Clin Oral Investig; 2014 Sep; 18(7):1725-30. PubMed ID: 24264641
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.
Franceschini D; Paroli M; Francavilla V; Videtta M; Morrone S; Labbadia G; Cerino A; Mondelli MU; Barnaba V
J Clin Invest; 2009 Mar; 119(3):551-64. PubMed ID: 19229109
[TBL] [Abstract][Full Text] [Related]
11. CD4
Niedźwiecki M; Budziło O; Zieliński M; Adamkiewicz-Drożyńska E; Maciejka-Kembłowska L; Szczepański T; Trzonkowski P
J Immunol Res; 2018; 2018():1292404. PubMed ID: 30003111
[TBL] [Abstract][Full Text] [Related]
12. Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1.
Savage ND; de Boer T; Walburg KV; Joosten SA; van Meijgaarden K; Geluk A; Ottenhoff TH
J Immunol; 2008 Aug; 181(3):2220-6. PubMed ID: 18641362
[TBL] [Abstract][Full Text] [Related]
13. Phosphoantigen-activated V gamma 2V delta 2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection.
Gong G; Shao L; Wang Y; Chen CY; Huang D; Yao S; Zhan X; Sicard H; Wang R; Chen ZW
Blood; 2009 Jan; 113(4):837-45. PubMed ID: 18981295
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
15. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.
Zhang HH; Mei MH; Fei R; Liao WJ; Wang XY; Qin LL; Wang JH; Wei L; Chen HS
Int J Oncol; 2010 Apr; 36(4):841-8. PubMed ID: 20198327
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of Foxp3+ CD4+ CD25+ regulatory cells in peripheral blood of patients with SLE].
Wei HG; Cai B; Wang LL; Li J; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):432-5. PubMed ID: 17488604
[TBL] [Abstract][Full Text] [Related]
18. The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection.
Mariano FS; Gutierrez FR; Pavanelli WR; Milanezi CM; Cavassani KA; Moreira AP; Ferreira BR; Cunha FQ; Cardoso CR; Silva JS
Microbes Infect; 2008 Jun; 10(7):825-33. PubMed ID: 18538611
[TBL] [Abstract][Full Text] [Related]
19. Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells.
Hilchey SP; De A; Rimsza LM; Bankert RB; Bernstein SH
J Immunol; 2007 Apr; 178(7):4051-61. PubMed ID: 17371959
[TBL] [Abstract][Full Text] [Related]
20. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?
Hmida NB; Ben Ahmed M; Moussa A; Rejeb MB; Said Y; Kourda N; Meresse B; Abdeladhim M; Louzir H; Cerf-Bensussan N
Am J Gastroenterol; 2012 Apr; 107(4):604-11. PubMed ID: 22108452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]